Nexalis Therapeutics Ltd Healthcare
Biotech

$TBC

High $0.01	Low $0.01	Trades -	Turnover $0	Volume 7,000
21 July 2026 at 11:36pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code NX1	Name Nexalis Therapeutics Ltd	Country AU	Currency AUD
GIC Sector N/A	GIC Group N/A	GIC Industry N/A	GIC Sub Industry N/A
Sector Healthcare	IPO Date N/A	Fiscal Year December	Type Common Stock
Shares Outstanding 253,037,323	Shares Floated 76,948,592	Held by Insiders 82.316%	Held by Institutions 0%

Directors & Officers

Name & Education	Position
Mr. Darryl Davies B.Sc.	CEO & Interim Executive Director
Dr. Robert Jenny B.A., B.Sc., Ph.D.	Chief Scientific Officer
Mr. Greg Hammond	Chief Financial Officer
Mr. Srinivasa Rao Suryadevara	Executive Vice President

NX1 Historic Dividends

Date	Amount
We found no dividends on record for NX1.

End of Day Prices

Date	Close	Volume	Change
21-Jul	$0.01	0	0.00 (0.00%)
20-Jul	$0.01	7,000	0.00 (0.00%)
17-Jul	$0.01	62,500	+0.01
1 up, 0 down, and 2 flat days

Market Cap (21-Jul) $2,783,410	EBITDA -	PE 0.00	Book Value $0.00
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.01	Profit Margin N/A
Operating Margin -160.44%	ROA 86.71%	ROE 0%	Revenue (FY) $986,434
Revenue per Share $0.01	Gross Profit (FY) $986,434	Q' YOY Revenue Growth 55.1%	Q' YOY Earnings Growth -

Nexalis Therapeutics Ltd Healthcare
Biotech

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

NX1 Historic Dividends

Followers

Prices

Announcements

End of Day Prices

NX1 Nexalis Therapeutics Ltd Healthcare Biotech

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

NX1 Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Nexalis Therapeutics Ltd Healthcare
Biotech